These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15311154)

  • 21. A comprehensive study on hemostasis in CAPD patients treated with erythropoietin.
    Malyszko J; Suchowierska E; Malyszko JS; Mysliwiec M
    Perit Dial Int; 2002; 22(5):582-92. PubMed ID: 12455569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.
    Gocmen AY; Ocak GA; Ozbilim G; Delibas N; Gumuslu S
    Can J Physiol Pharmacol; 2013 Sep; 91(9):680-5. PubMed ID: 23984971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation.
    Hognestad A; Aukrust P; Wergeland R; Stokke O; Gullestad L; Semb AG; Holm T; Andreassen AK; Kjekshus JK
    Clin Cardiol; 2004 Apr; 27(4):199-203. PubMed ID: 15119693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients.
    Chang JW; Yang WS; Min WK; Lee SK; Park JS; Kim SB
    Am J Kidney Dis; 2002 Jun; 39(6):1213-7. PubMed ID: 12046033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simvastatin reduces CD40 expression in an experimental model of early arterialization of saphenous vein graft.
    Chello M; Spadaccio C; Anselmi A; Patti G; Lusini M; Di Sciascio G; Covino E
    J Surg Res; 2006 Dec; 136(2):302-8. PubMed ID: 17046792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
    Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
    Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simvastain affects TAFI and thrombomodulin in CAPD patients.
    Małyszko J; Małyszko JS; Hryszko T; Myśliwiec M
    Thromb Haemost; 2001 Sep; 86(3):930-1. PubMed ID: 11583330
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacology and clinical experience with simvastatin.
    Hess DC; Fagan SC
    Expert Opin Pharmacother; 2001 Jan; 2(1):153-63. PubMed ID: 11336576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia.
    Garlichs CD; John S; Schmeisser A; Eskafi S; Stumpf C; Karl M; Goppelt-Struebe M; Schmieder R; Daniel WG
    Circulation; 2001 Nov; 104(20):2395-400. PubMed ID: 11705814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.
    Saltissi D; Morgan C; Rigby RJ; Westhuyzen J
    Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.
    Kirmizis D; Papagianni A; Dogrammatzi F; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
    Ren Fail; 2012; 34(9):1135-9. PubMed ID: 22950641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of simvastatin on angiogenic growth factors released at the site of microvascular injury.
    Undas A; Celińska-Lowenhoff M; Stepień E; Nizankowski R; Tracz W; Szczeklik A
    Thromb Haemost; 2006 Jun; 95(6):1045-7. PubMed ID: 16732391
    [No Abstract]   [Full Text] [Related]  

  • 33. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia.
    Sebestjen M; Boh M; Keber I
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
    Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
    Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetes.
    Neubauer H; Setiadi P; Günesdogan B; Pinto A; Börgel J; Mügge A
    Diabet Med; 2010 Apr; 27(4):384-90. PubMed ID: 20536508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of simvastatin or ezetimibe on tissue factor, von Willebrand's factor and C-reactive protein in patients with hypercholesterolaemia.
    Kostakou P; Kolovou G; Anagnostopoulou K; Theodoridis T; Galea V; Mihas C; Christopoulou-Cokkinou V; Cokkinos DV
    Arch Cardiovasc Dis; 2010 Jan; 103(1):26-32. PubMed ID: 20142117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin.
    Pignatelli P; Sanguigni V; Lenti L; Loffredo L; Carnevale R; Sorge R; Violi F
    J Thromb Haemost; 2007 Jun; 5(6):1170-8. PubMed ID: 17388962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.
    Schwabe RF; Engelmann H; Hess S; Fricke H
    Clin Exp Immunol; 1999 Jul; 117(1):153-8. PubMed ID: 10403929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.